Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: Results from the LIPID trial

Diabetes, a major health problem worldwide, increases the risk of cardiovascular disease and its associated mortality: The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) trial showed that cholesterol-lowering treatment with pravastatin reduced mortality and coronary heart diseas...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes care 2003-10, Vol.26 (10), p.2713-2721
Hauptverfasser:	KEECH, Anthony, COLQUHOUN, David, TONKIN, Andrew, BEST, James, KIRBY, Adrienne, SIMES, R. John, HUNT, David, HAGUE, Wendy, BELLER, Elaine, ARULCHELVAM, Manjula, BAKER, Jennifer
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Angina, Unstable - mortality Angina, Unstable - prevention & control Anticholesteremic Agents - therapeutic use Associated diseases and complications Biological and medical sciences Blood Glucose Cardiovascular diseases Cardiovascular Diseases - mortality Cardiovascular Diseases - prevention & control Coronary Artery Disease - mortality Coronary Artery Disease - prevention & control Coronary Restenosis - mortality Coronary Restenosis - prevention & control Diabetes Mellitus, Type 2 - mortality Diabetes. Impaired glucose tolerance Endocrine pancreas. Apud cells (diseases) Endocrinopathies Evaluation Fasting Female Follow-Up Studies Glucose Intolerance - mortality Humans Hyperlipidemias - drug therapy Hyperlipidemias - mortality Male Medical sciences Middle Aged Myocardial Infarction - mortality Myocardial Infarction - prevention & control Pravastatin Pravastatin - therapeutic use Prevention Risk Factors Stroke - mortality Stroke - prevention & control Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!